Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27854037

CC(C)(C)OC=O.Cc1ccccn1.[2H]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.46
▸ GRM5 P41594 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ XBP1 P17861 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ FDPS P14324 1/20 0.33
▸ NFE2L2 Q16236 2/20 0.32
▸ PLCG1 P19174 1/20 0.32
▸ KDM4E B2RXH2 4/20 0.32
▸ TRIM24 O15164 1/20 0.32
▸ TRIM33 Q9UPN9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipyridyl SCHEMBL27745333 0.81 KDM4E (0.54) TDP1ALDH1A1SMN1; SMN2NPC1RAB9A
Formic Acid Methyl Ester SCHEMBL28046510 0.81 GRM5 (0.39) GRM5ALDH1A1SMN1; SMN2NPC1RAB9A
Tert-Butyl Formate SCHEMBL27549647 0.79 TDP1 (0.57) TDP1GRM5ALDH1A1SMN1; SMN2NPC1
Tert-Butyl Formate SCHEMBL27580501 0.79 TDP1 (0.46) TDP1ALDH1A1SMN1; SMN2NPC1RAB9A
Acetaldehyde SCHEMBL27271887 0.78 GRM5 (0.42) TDP1GRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL28151639 0.77 GRM5 (0.41) TDP1GRM5ALDH1A1SMN1; SMN2NPC1
Formamide SCHEMBL27759772 0.77 NOS3 (0.41) GRM5ALDH1A1SMN1; SMN2NPC1RAB9A
Formic Acid SCHEMBL27263940 0.77 ALDH1A1 (0.43) GRM5ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL29599136 0.76 KDM4E (0.50) TDP1GRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL2684 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102666507-A Oxazine derivatives and their use in the treatment of neurological disorders NOVARTIS AG 2012-09-12 — — CN disclosed
CN-102471293-A Oxazine derivatives and their use as BACE inhibitors for the treatment of neurological disorders NOVARTIS AG 2012-05-23 — — CN disclosed
Send feedback